30 July 2026
For this New Zealand-born healthcare technology company, success has been built over time through a unifying purpose, clear strategy and disciplined execution.
From less than $200 million in revenue in 2001 to $2.3 billion in the 2026 financial year, the company has delivered strong growth while continuing to invest in the people, research and infrastructure that underpin its long-term success.
What began as a prototype humidifier to support respiratory patients in hospitals has expanded to a portfolio of products that help improve patient care. Broadly categorised into hospital and homecare product groups, the company’s devices and therapies are used for acute and chronic respiratory support, surgery, and the treatment of obstructive sleep apnea.
Fisher & Paykel Healthcare now has over 7,600 employees based in 55 countries. Aotearoa New Zealand remains the company’s headquarters, employing over half of its workforce. The business provides numerous hi-tech job opportunities in product development, ICT, quality, and shared services, such as human resources and finance. Well-established internship and graduate programmes offer young Kiwis a great start with their careers as well.
Innovation remains the company’s cornerstone. Fisher & Paykel Healthcare invests around 10% of revenue in research and development every year. That adds up to more than $1.5 billion over the past decade, the majority of which has been in New Zealand.
With nearly 1,000 people engaged in R&D, the drive to develop original and effective products and therapies fuels a pipeline of advanced healthcare technologies. Collaborations with healthcare providers in New Zealand and overseas enable R&D teams to grow their knowledge of various care environments. Gaining a deep understanding of real clinical problems early in the development process leads to innovative and valued solutions for better patient care.
The company’s East Tāmaki campus in Auckland has specialised laboratories and high-tech model shops. A state-of-the-art simulation centre allows product designers to replicate hospital environments, supporting product and usability testing and education across a range of therapies.
Alongside product innovation, the business is developing the infrastructure needed to support future growth. The company has acquired land in Karaka, Auckland, for a second campus in New Zealand. Located near the Ngākōroa train station and planned residential developments, the new site will be developed over the next several decades.
For Aotearoa’s technology sector, Fisher & Paykel Healthcare demonstrates the power of long-term thinking. The company continues to show how New Zealand innovation can create both economic value and meaningful impact for millions of patients around the world.